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The charge densities on the ligand atoms were calculated via DFT calculations. The complexes were
synthesized by direct reaction between SmCl3 and bidentate ligands contains (N,N), (S,N), (O,O)
and (N,O) donor atoms. The investigated complexes were soluble in polar solvents, and could be
use as potential radiopharmaceuticals complexes. The antibacterial activities of the investigated
complexes have been tested and evaluated.
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lsevier1. Introduction
Metals offer many opportunities for designing radiopharma-
ceuticals by modifying the environment around the metal and
allowing speciﬁc in vivo targeting to be incorporated into the
molecule (Mikheev and Kamenskaya, 1991; Desai and Thakur,
1985). The coordination compounds of certain transition met-
als have wide applications as pharmaceuticals and radiophar-
maceuticals. Important consideration in the design and use of
these complexes in biological system were their stability and
behavior in biological organs (Lever et al., 2007; Saha, 1989;
Clarke et al., 1989). [Sm(EDTMP)Æ3H2O] complexes have been
approved for bone imaging. A mayo clinic study indicates that
radioactive drug samarium may expand treatment options for
osteosarcoma (Addison et al., 1998). 153Sm-PDTMP (samar-
ium-153-propylene diamine tetra-methylene phosphonate)
392 N.S. Al-Hokbany, R.M. Mahfouzwas also safe and effective for the treatment of patients with
painful bone metastases. The mixed ligands concept and
particularly the SN/N combination have been applied for the
preparation of several samarium complexes (Jurisson et al.,
2004). The literature shows that a search for new radiopharma-
ceuticals requires studies of new samarium complexes with
nitrogen and sulfur donor sets, as well as investigations of the
chemical behavior of their 153Sm analogs. In this work, the syn-
thetic and characterization of the novel complexes of general
form [Sm(N,N)(S,O)OH2] (Fogelman et al., 1997). These com-
plexes of samarium have been prepared using bidentate ligands
containing (N,N), (N,S), (O,O) and (N,O) donor sites and were
characterized using conventional physico-chemical techniques
of analysis and their antibacterial activities were tested and
evaluated.
2. Experimental
2.1. Material and methods
All chemical used were of analytical grade and used without
further puriﬁcation. IR spectroscopy was recorded on a Per-
kin–Elmer spectrophotometer 1000 in the spectral range 200–
4000 cm1 with sample in the form of KBr pellets. UV–Vis
spectra were recorded on UV–Vis Beckman Du-70 spectropho-
tometer in the range 190–700 nm. 1H–13C NMR spectra were
measured in (DMSO-d6 and CDCl3) as solvents on a JOEL-
NMR 400 MHz spectrometer. Elemental analyses were carried
out on Perkin–Elmer 2400 CHNSO elemental analyzer.
Samarium content in the investigated complexes was deter-
mined gravimetrically by precipitation as Sm2O3. The analyti-
cal percentage of Cl in its ionic or covalent character was
estimated by precipitation as AgCl at 30 C using AgNO3 re-
agent (Vogel, 1989). TG measurements were carried out using
a Netzsch STA-429 thermal analyzer. The weight loss was
measured from ambient temperature up to 700 C at a heating
rate of ‘‘10 C/min’’. Electrophoresis in different pH medium
was measured on Shandon-Vokarn 400–100 instrument (Eng-
land). The applied voltage was 500 and the electrolyte solution
was buffer solution in different pH. The antibacterial activity
of the free ligands and their complexes were tested against var-
ious gram-positive and gram-negative bacteria cultures by
using the agar diffusion method (Garcia et al., 1986). The bac-
terial strains were grown in Mueller–Hinton agar (Merck)
plates at ‘‘37 C’’ for 18 h, and then were diluted to a ﬁnal con-
centration of approximately 106 CFU/ml. About 0.1 ml of the
each bacterial suspension was spread over the surface of the
Mueller–Hinton agar plates. A ‘‘10 ll’’ of ‘‘10 mg/ml’’ of each
free ligand and the investigated complexes was absorbed onto
a sterilized ﬁlter paper disk of 6 mm diameter. The sterilized ﬁl-Table 1 Stoichiometric amounts of the reactants.
Complex Metal salt
[Sm(IMZ)2Cl(H2O)3] SmCl3 (0.51 g, 2
[Sm(IMZ)(Ac)2(H2O)3] Sm(Ac)3 (0.74 g
[Sm(L-CTN)2Cl(H2O)2] SmCl3 (0.51 g, 2
[Sm(NETU)Cl2(H2O)2] SmCl3 (0.51 g, 2
[Sm(THBA)3] SmCl3 (0.51 g, 2
[Sm(HOTCA)Cl2(H2O)] SmCl3 (0.51 g, 2
[Sm(TTA)3] SmCl3 (0.51 g, 2ter paper disk were dried under sterile condition and then
immediately placed on the surface of Mueller–Hinton agar
plates after their inoculation with the test bacterium. The
plates were incubated at ‘‘37 C’’ for 24 h and the diameter
(mm) of the inhibition zone was recorded.
2.2. Preparation of complexes
The stoichiometric amounts of samarium salts and the investi-
gated ligands are listed in Table 1. The required amounts of
metal salts (1 mmol) were dissolved separately in 15 ml water
and added dropwise to 30 ml of an ethanol solution containing
the corresponding amount of the investigated ligand (3 mmol)
while stirring at room temperature. The reaction mixture in
each case was reﬂuxed for 3 h while changes in color were
observed. The reaction mixture was dried by rotator evapora-
tor. The resulting solid product was separated out by ﬁltration,
washed with absolute ethanol and diethyl ether, then redis-
solved in hot acetone and allowed to stand for crystallization.
For preparation of [Sm(THBA)3] and [Sm(HOT-
CA)Cl2(H2O)] the pH of the reaction mixture was adjusted
to 10 by addition of NaOH (6 mmol). For preparation of
[Sm(TTA)3] the pH of the reaction medium was adjust to
pH  5 using acetate buffer.
3. Results and discussion
3.1. The Mullikien charge calculations of the ligands
Calculations of the electronic charge–density distribution were
performed on Gaussian 98 program employing B3LYP func-
tion with 6-31G base set (Buckingham, 1997). It has been
found that, the most Mullikien electronic charge calculations
for NH (0.660) is the best site to coordinate with Sm in
IMZ molecule as seen in Fig. 1. The results showed that, for
HTTA molecule, the O, O atoms (10, 14) (0.163, 0.138),
respectively, have the highest electrons density than the other
atoms, so it is preferable donor atoms for coordination with
Sm. The atoms OH (0.256) and O (0.192) for OTCA-ligand
and NH (0.308) of NETU ligand, have the higher charge
atoms, as best site preferable to coordinated with Sm.
The micro-analytical data of the investigated complexes are
tabulated in Table 2 showed a good agreement between exper-
imentally and theoretically calculated data as included in the
experimental section.
3.2. The spectroscopy studies
The infrared spectra of complexes summarized in Table 3 show
bands in the region 3280–3450 cm1 corresponding to t OHLigand
mmol) IMZ (0.41 g, 6 mmol)
, 2 mmol) IMZ (0.41 g, 6 mmol)
mmol) L-CTN (0.73 g, 6 mmol)
mmol) NETU (0.61 g, 6 mmol)
mmol) THBA (0.85 g, 6 mmol)
mmol) H2OTCA (0.9 g, 6 mmol)
mmol) HTTA (1.3 g, 6 mmol)
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Figure 1 The calculations of charge densities of ligands.
Table 2 The analytical data of complexes.
Complex Empirical formula Decomposition
temp. (C)
Color Yield % Elemental analysis (found) calc.%
C N N O Cl Sm
[Sm(IMZ)2Cl(H2O)3] C6H12N4ClO3Sm 300 Gray 85.9 (19.28) (3.2) (14.04) (12.73) (9.7) (40)
19.2 3.23 14.09 12.83 9.4 40.2
[Sm(IMZ)(Ac)2(H2O)3] C7H15N2O7Sm 280 Cream 75.9 (21.57) (3.69) (7.16) (28.90) – (38.80)
21.59 3.85 7.11 28.75 – 38.5
[Sm(L-CTN)2Cl(H2O)2] C6H12N2S2O6ClSm 295 Cream 82.7 (15.82) (2.5) (6.14) (20.76) (7.7) (32.4)
15.73 2.62 6.11 20.98 7.75 32.7
[Sm(NETU)Cl2(H2O)2] C3H9N2SO2Cl2Sm 300 Cream 83.8 (10.62) (2.59) (7.08) (8.92) (19.7) (41.47)
10.4 2.51 7.8 8.9 19.81 41.9
[Sm(THBA)3] C12H9N6S3O6Sm 300 Cream 82.2 (24.67) (1.78) (14.6) (16.73) – (25.83)
24.48 1.55 14.51 16.47 – 25.91
[Sm(HOTCA)Cl2H2O] C4H6O4SNCl2Sm 290 White 85.3 (12.53) (1.64) (3.51) (16.54) (18.31) (39.2)
12.45 1.55 3.63 16.6 18.42 38.93
[Sm(TTA)3] C24H12O6F9S3Sm 230 Cream 85 (36.29) (1.7) – (12.02) – (19.03)
36.87 1.53 – 12.29 – 19.21
Preparation and characterization of new Sm(III) complexes with some bidentate ligands 393stretching and the bands at 1460–1580 cm1 vibration due to
HOH bending. Some bands are disappearing in some com-plexes such as OH and NH at 3414 and 3117 cm1, respec-
tively, these indicating that these donor atoms were
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394 N.S. Al-Hokbany, R.M. Mahfouzdeprotonated upon complexation. The t(C‚O) vibrations are
signiﬁcantly shifted and showing to lower in energy, than
HTTA free (1739 cm1). Which indicate coordination of the
chelate. New bands were showing, characteristic at 670,
470 and 330 cm1 for the Sm–O, Sm–N and Sm–Cl vibrations,
respectively (Pappalardo et al., 1982). The remainder of the
spectra were dominated by t(C‚C) stretching between 1400
and 1600 cm1 and t(C‚N) stretching ranging from 1600 to
1610 cm1.
1H–13C NMR studies are represented in Table 4 for com-
plexes and their corresponding free ligands. The 1H NMR
spectra of series of complexes show signals assigned to the
Ha,b,c,d (the protons of ring) in different chemical shifts due
to the anisotropic effect of metal site. In the 1H NMR spec-
trum of [SmO(IMZ)2Cl(OH2)3] complex, the imidazole ring
protons appear as two doublets and are shifted markedly down
ﬁeld in relative to the free ligand from (7 ppm and 7.7 ppm) to
(7.13 ppm and 7.7 ppm), respectively. The NH proton signal
for IMZ was absent in the spectrum of the complex. 13C
NMR spectra of the complex showed a signals at 135,
122 ppm attributed to (C‚N) bond and (C‚C) for IMZ ring.
13C NMR spectra of the studies complexes exhibit two new
characteristic C–S, C–N at lower ﬁeld 58, 45 ppm compared
to the free ligands indicating that coordination via the charged
thiolic sulfur and nitrogen atoms have occurred.
Table 5 show typical UV–visible spectra with almost two
signiﬁcant absorption bands, one of them in the UV region at
about 205–270 nm corresponding to the pﬁ p* band, and
the other in the visible, approximately at 350 nm, which is char-
acteristic for weak f–f transition. The intra- and intra ligand
transitions are assigned to the highest energy absorption band
at 240 nm . The weak f–f transition are formally forbidden,
they actually occur and provide evidence for covalent character
of metal–ligand bonds of the investigated complexes (Kumar,
1998). Compared to aqua-ions of samarium the f–f transition
bands of complexes display perturbations and increased inten-
sities due to complexes formation, presumable due to the nep-
helauxetic effect. Nephelauxetic ratio b, parameter of covalency
d and oscillator strength P were calculated and the values are
included in Table 5 (Mehta et al., 1985; Jøgensen et al., 1964;
Jøgensen and Judd, 1964). The b values are less than unity
and %d values are positive. These suggest partial covalent
bonding between Sm(III) and ligand. The oscillator strength
value indicates partial overlapping of metal–ligand orbitals
(Singh et al., 2007; Karraker; 1969; Coats and Redfern; 1964).
The mass spectra of the investigated complex (Fig. 2) show
all expected fragments. The mass spectra of the investigated
[Sm(THBA)3] complex show molecular peak with m/z 583.7
attributed to specie of [Sm(THBA)3]. The major peak at m/
z= 93 is assigned to the ligand peak as shown in Scheme 1.
3.3. The antibacterial activity
The antibacterial activity of the investigated complexes and the
free ligands were tested against various kinds of bacteria listed
in Table 8. Indicated that the investigated complexes have
some activities against the gram-negative bacteria particularly
Escherichia coli, with no signiﬁcant impacts on the gram-posi-
tive bacteria (Plant et al., 1969). The bioactivity studies indi-
cate that the antibacterial activities of the complexes do not
simply show the synergistic effect of ligand and samarium
ion. Compared with the ligand, the complexes display
Table 4 The NMR data for ligands and complexes (d, ppm) a,b.
Complexc 1H NMR (d ppm)a,b 13C NMR ppm
IMZ Hc (s, 7.66) Ha (s, 7.035) NH (s,12.3) C‚N (135.6) C‚C (122)
[Sm(IMZ)2Cl(H2O)3] Hc (s, 7.71) Ha (s, 7.039) – H2O (s, 3.70) C‚N (135) C‚C (123)
[Sm(IMZ)(Ac)2(H2O)3] Hc (s, 7.63) Ha (s, 7.103) – H2O (s, 3.34) CH3 (s, 1.97) C‚N (135.7) C‚C (123) CH3 (24) C–O (55)
L-CTN SH (s, 1.1) NH2 (s, 3.26) CH2 (d, 2.78) CH (t, 2,89) OH (s,11.0) C‚O (177) CH (39.5) CH2 (24.6)
[Sm(L-CTN)2Cl(H2O)2] SH (s, 1.5) NH2 (s, 3.20) CH2 (d, 2.77) CH (t, 2.89) – H2O (s, 3.6) C–O (55.32) CH (39.2) CH2 (24.7)
NETU Ha, Hb (s, 3.71) NH (s, 2.02) C‚S (183) C–N (45.68)
[Sm(NETU)Cl2(H2O)2] Ha (m, 3.28) Hb (s, 3.60) NH (s, 1.19) H2O (s, 4.8) C–S (58.30) C–N (45.10)
THBA OH (s, 12.19) SH (s, 3.53) Ha (s, 2.90) C‚N (171) C‚C (112)
[Sm(THBA)3] OH (s, 11.90) SH (s, 3.42) Ha (s, 3.16) C‚N (171) C‚C (112)
HTTA OH (s, 13.6) thiophene ring (m, 8.4) CH enolic (s, 6.2) C‚O (165) CH2 (30) thiophene ring, CF3 (140.2)
[Sm(TTA)3] Thiophene ring (m, 8.2) CH enolic (s, 7.2) C‚O (165) CH2 (30) thiophene ring, CF3 (140.2)
a s = singlet, d = doublet, t = triplet, m = multiplet.
b Nomenclature of position to hydrogen atom.
c Labeling of H atoms of the free ligands are shown below.
Preparation and characterization of new Sm(III) complexes with some bidentate ligands 395strengthening or weakening antibacterial activities, depending
on the type of the bacteria.
3.4. Determination of kinetic parameters of the thermal
decomposition
Thermal decomposition behavior of investigated complexes
was followed using thermogravimetric (TG) and differential
thermogravimetric (DTG) techniques. The decomposition oc-
curred in one or two steps depending on the type of the com-
plexes investigated. Table 6 summarized the results of the
thermal decomposition of the investigated complexes.
The Horowitz and Metzger equation
Cs ¼ n1=1nTable 5 The electronic data of complexes.
Complex kmax, nm (e, L mol
1 cm1)
[Sm(IMZ)2Cl(H2O)3] 208 (3000), 260 (260)
[Sm(IMZ)(Ac)2(H2O)3] 205 (1290), 265 (310)
[Sm(L-CTN)2Cl(H2O)2] 218 (297), 337 (5.8)
[Sm(NETU)Cl2(H2O)2] 210 (484), 232 (686), 339 (20)
[Sm(THBA)3] 205 (2273), 264 (1910), 278 (1702)
[Sm(HOTCA)Cl2ÆH2O] 204 (1000), 240 (1723), 284 (50)
[Sm(TTA)3] 267 (561), 369 (11.51)where, Cs is the weight fraction of the substance present at the
DTG peak temperature Ts, is given asCs ¼Ws Wf
Wi Wf ð1Þ
This equation was applied for the determination of the reac-
tion order (n) of the decomposition. Here Ws stand for weight
remaining at a given temperature Ts, i.e. the DTG peak tem-
perature Wi and Wf are the initial and ﬁnal weight of sub-
stance, respectively (Garcia et al., 1987). The calculated
values of Cs are in range 0.3–0.4 which indicated that the
decomposition follows ﬁrst order kinetic for both the dehydra-
tion and the main decomposition steps.Assignment Spectral parameters
pﬁ p*, pﬁ p* –
pﬁ p*, pﬁ p* –
pﬁ p*, 6H5/2ﬁ 4L17/2 –
b= 0.985
%d= 1.5
P= 7 · 106
pﬁ p*, pﬁ p*, 6H5/2ﬁ 4L17/2 –
b= 0.979
%d= 2.1
P= 24 · 106
pﬁ p*, pﬁ p*, nﬁ p* –
pﬁ p*, pﬁ p*, nﬁ p* –
pﬁ p*, 6H5/2ﬁ 4D1/2 –
b= 0.981
%d= 1.9
P= 15 · 106
Figure 2 Mass-spectra of [Sm(THBA)3] complex.
396 N.S. Al-Hokbany, R.M. MahfouzThe following Coats-Redforn equations were applied for
determination of activation energy Ea and Arrhenius constant
A, of the decomposition (Garcia et al., 1987; Plant et al., 1969).
ln
 lnð1 aÞ
T2
¼ Ea
RT
þ ln AR
UEa
n ¼ 1 ð2Þ
ln
 lnð1 aÞ
T2ð1 nÞ
 1n
¼ Ea
RT
þ ln AR
UEa
n – 1 ð3Þ
where a is the fraction decomposition at time t and is given by
a ¼ m0 mt
m0 mf ð4Þ
(m0 is the mass at the beginning of the decomposition steps, mt
is the mass at time t, mf is the mass at the end of the decompo-NN
HS
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O N
N
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HO
O
Sm N N
SH
OH
O
N
HS
HO
N
N
+
N
N
+
+
m\z=582
m\z=77
N
N
Scheme 1 FAB+ mass fragment
Table 6 Kinetic and thermodynamic data of thermal decomposi
equations.
Complex Decomposition steps (C) DEa (kJ mol1) D
[Sm(IMZ)2Cl(H2O)3] 80–180 52.5 
185–480 75.8 
[Sm(IMZ)(Ac)2(H2O)3] 100–210 94.8 
215–670 127.6 
[Sm(L-CTN)2Cl(H2O)2] 100–180 106.4 
200–600 136.3 
[Sm(NETU)Cl2(H2O)2] 100–145 86.2 
150–600 195.8 
[Sm(THBA)3] 200–640 128.4 
[Sm(HOTCA)Cl2ÆH2O] 80–180 70.9 
100–590 90.2 
[Sm(TTA)3] 230–400 170 sition steps), Ea, A, R, u and Ts are activation energy of
decomposition, Arrhenius constant, gas constant, heating rate
and temperature at DTG peak, respectively. The kinetic
parameters were calculated from the plots of Eqs. (2) and (3)
versus ‘‘1/T’’ and (T  Ts), respectively. The correlation coef-
ﬁcient r (>0.95) is computed using the least-square method
for Eqs. (2) and (3). The activation entropy S*, activation en-
thalpy H* and the free energy of activation G* were calculated
using the following equations:
S ¼ 2:303 log Ah
KT
 
R ð5Þ
H ¼ E  RT ð6Þ
G ¼ H  TsS ð7Þ
K and h are the Boltzman and Plank constants, respectively.
The temperature T involved in the calculations was selected
as the temperature at the end of the decomposition step. The
calculated kinetic and thermodynamic values are reported in
Table 7 for the various decomposition steps.The kinetic
parameters, especially Ea and S*, are helpful in assigning the
strength of the bonding of both water molecules and ligand
moieties with the metal ion. The values of the major decompo-
sition step of the studied compounds i.e. the stages of
the decomposition to volatile products are in the rangeN
ON
N
O
Sm N N
SH
OH
O NN
ON
N
O
Sm N N
OH
O
NN
O
Sm N N
O
N
N
O
N
N
N
N
Om\z=528.6
m\z=428.5
m\z=335m\z=93
O
-
ation pattern of [Sm(THBA)3].
tion of the investigated complexes according to Coats-Edfern
S* (J K1 mol1) DH* (kJ mol1) DG* (kJ mol1) A (s1) n
240.3 48.9 150.6 2.4 „1
232.7 71.1 202.1 8.2 „1
241.2 91.3 196.9 2.2 1
245.2 123.6 244.2 1.5 1
217.8 102.9 195 36.9 „1
232.3 132.3 244.5 7.8 1
251.3 82.7 186.5 0.64 1
214.5 191.8 286.9 57.7 1
250.8 122.9 289.2 1.1 1
261.4 66.3 208.1 0.22 1
260 87.6 228 0.25 1
252.2 163 227 0.81 1
Table 7 The TG data of complexes.
Complex Step Temp. (C) Assignment Decomposition step Anal.
(calc.) %
[Sm(IMZ)2Cl(H2O)3] First 80–180 Loss of water 14.45 (14)
Second 185–480 Loss of volatile 45.32 (45.6)
[Sm(IMZ)(Ac)2(H2O)3] First 100–210 Loss of water 13.8 (15)
Second 215–670 Loss of volatile 47.5 (46.43)
[Sm(L-CTN)2Cl(H2O)2] First 100–180 Loss of water 7.78 (7.5)
Second 200–600 Loss of volatile 59.74 (60)
[Sm(NETU)Cl2(H2O)2] First 100–145 Loss of water 10.04 (9.53)
Second 150–600 Loss of volatile 48 (47.68)
[Sm(THBA)3] First 200–640 Loss of volatile 74 (74)
[Sm(HOTCA)Cl2ÆH2O] First 90–180 Loss of water 4.6 (4.02)
Second 180–660 Loss of volatile 56 (53.72)
[Sm(TTA)3] First 230–400 Loss of volatile 80 (81.4)
Table 8 Antibacterial activities of investigated complexes.
Organism Actual inhibition zone diameter in (mm)a
[Sm(IMZ)(Ac)2(H2O)3] [Sm(HOTCA)Cl2H2O] [Sm(THBA)3]
Gram-negative Escherichia coli ATCC 25922 13.5 15.5 15
Yersinia pseudetuberculosis ATCC10275 9 10 11
Y. enterocolitica ATCC 23715 9 10 12
Shigella sonnei KKUH934 9 11 10
Salmonella typhi KKUH1012 Trace 9 10
Gram-positive Staphylococcus aureus Trace 9 9
S. epidermidis 0.0 Trace 9
Streptococcus faecalis NCTC 370 8 Trace Trace
Bacillus megaterium CBSC 15-4900A 9 8 Trace
Bacillus cereus CBSC 15-4870A 8 7 7
a Trace: inhibition zone is less than 8 mm in diameter.
Preparation and characterization of new Sm(III) complexes with some bidentate ligands 397220–285 kJ/mol which indicates that the ligand is strongly
bound to the metal ion. The activation energy for the dehydra-
tion step of complexes located in the range 100–130 kJ/mol.
These values are comparable to the generally accepted values
of activation energy for coordinated water. The negative val-
ues indicated that the activated complexes have a more or-
dered structure than the reactants and that the complexation
reactions are slower than normal.
4. Conclusion
In this study new complexes of samarium have been prepared
using bidentate ligands containing (N,N), (N,S), (O,O) and
(N,O) donor sites. A synthesis of series of novel samarium com-
plexes, [Sm(IMZ)2Cl(H2O)3], [Sm(IMZ)(Ac)2(H2O)3], [Sm(L-
CTN)2Cl(H2O)2], [Sm(NETU)Cl2(H2O)2], [Sm(THBA)3],
[Sm(HOTCA)Cl2H2O] and [Sm (TTA)3] have been prepared
and full characterized using conventional physico-chemical
techniques of analysis and their antibacterial activities were
tested and evaluated.Acknowledgement
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